GLENVIEW CAPITAL MANAGEMENT, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1138995
NEW YORK, NY
Position in TEVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$200,605,826
-$321,231,896 QoQ
Shares Held
6,660,220
-60.2% QoQ
Ownership
0.572%
of shares outstanding
% of Portfolio
5.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GLENVIEW CAPITAL MANAGEMENT, LLC holds $323,374,492 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (62.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
6,660,220 | $200,605,826 | |
| 2 | VTRS |
Viatris Inc
|
9,087,244 | $122,768,666 |
All Filings in TEVA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $200,605,826 | 6,660,220 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $521,837,722 | 16,720,209 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $337,192,136 | 16,692,680 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $265,213,977 | 15,824,223 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $227,147,712 | 14,778,641 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $186,377,380 | 8,456,324 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $152,382,958 | 8,456,324 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $148,811,666 | 9,157,641 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $105,843,117 | 7,501,284 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,752,368 | 1,604,633 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||